Case Study: Catalina
Ovarian cancerA longitudinal evidence-based case study
Understanding the clinical course, treatment context and evolving evidence.
- Public revision 2 ·
Educational reference · Not individualized medical advice.
Clinical timeline
Events will be populated from reviewed records.
12 events
-
Interval
Diagnosis of non-Hodgkin lymphoma
Non-Hodgkin lymphoma diagnosed in 2000, according to the 2022 medical summary, which gives the year only.
-
Interval
Radiotherapy for the lymphoma, 30 fractions, completed in 2000
Radiotherapy for the lymphoma, 30 fractions, completed in 2000 according to the medical summary.
-
Approximate date
Lymphoma surveillance from 2001
Under surveillance for the lymphoma from 2001, according to the medical summary.
-
Approximate date
Diagnosis of ovarian cancer, stage IV (pleural effusion), poorly differentiated adenocarcinoma
Ovarian cancer, stage IV because of a pleural effusion, with a diagnosis of poorly differentiated adenocarcinoma, as stated in the 2022 medical summary.
-
Exact date
Laparoscopy at another institution
Laparoscopy performed on 17 October 2020 at an institution other than the IMSS Oncology Hospital, according to the medical summary.
-
Exact date
Adjuvant chemotherapy, four cycles, completed
Adjuvant chemotherapy, four cycles, administered at the IMSS Oncology Hospital and completed on 10 March 2021, according to the medical summary.
-
Exact date
Interval cytoreductive surgery, reported as optimal
Interval cytoreductive surgery on 17 May 2021, reported as optimal: hysterectomy, bilateral salpingo-oophorectomy, omentectomy and bilateral pelvic lymphadenectomy, without complications.
-
Exact date
Hospital discharge after the cytoreduction
Discharged on 19 May 2021 after the cytoreduction, without complications, according to the medical summary.
-
Exact date
Tumor marker reported negative at the gynecologic-oncology evaluation
At the gynecologic-oncology evaluation of 26 January 2022 the tumor marker was reported negative, according to the medical summary.
-
Exact date
Evaluation of 26 January 2022: stable, no evidence of recurrence, ECOG 0
At the last gynecologic-oncology evaluation recorded in the summary (26 January 2022) she reported no symptoms, was considered stable with no evidence of recurrence, and had an ECOG performance status of 0.
-
Exact date
No evidence of disease, stable, as of the medical summary
As of the medical summary of 18 May 2022, the patient was reported without evidence of disease and stable.
-
about four months after 26 January 2022, with a control CT (exact date not stated) Unknown date
Follow-up appointment with a control CT scan
A follow-up visit was scheduled about four months after the 26 January 2022 evaluation, with a control CT scan, according to the medical summary.
